Manufacturing

Articles

Recipharm’s new high speed filling line, designed for pre-filled syringes and cartridges, is expected to be operational by May 2023.

Recipharm to Add High-Speed Filling Line to Wasserburg Facility

Lubrizol has launched Apisolex technology to improve solubility and simplify the manufacturing of parenteral drug products.

Lubrizol Launches Apisolex Technology 

Takeda’s TAKHZYRO prefilled syringe is now available for patients with hereditary angioedema aged 12 years and older in the United States.

Takeda’s TAKHZYRO Prefilled Syringe Now Available for Patients with Hereditary Angioedema

Eli Lilly and Company is investing $1 billion to establish a new manufacturing site in Concord, NC, to manufacture parenteral products and devices.

Lilly to Invest $1 Billion to Build New Parenteral Manufacturing Facility in North Carolina

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Isolators move into smaller-volume processes, including cell and gene therapy manufacturing.

Trends in Isolator Equipment

Hallie Forcinio is packing editor for Pharmaceutical Technology and Pharmaceutical Technology Europe, editorhal@sbcglobal.net.

New equipment meets needs for faster vial labeling and RFID for unit-level serialization.

Trends in Vial Labeling Equipment

Trends and technologies in pharmaceutical manufacturing were highlighted on the show floor and in the conference sessions on the INTERPHEX Innovation Stage.

Equipment Innovations for Pharma Manufacturing

Baxter will invest $100 million in new lyophilization equipment and an additional aseptic syringe filling line at its Halle/Westfalen (Germany) location.

Baxter Invests in its German Sterile Fill/Finish Manufacturing Facility

In this collaboration, Takeda will utilize Poseida's biodegradable DNA and RNA nanoparticle delivery technology and other proprietary genetic engineering platforms for the research and development of gene therapies.

Poseida Therapeutics and Takeda Partner to Develop Non-Viral In-Vivo Gene Therapy Programs

Conventional and robotic automation inside closed systems reduces risk. 

Manufacturing, Parenterals and Injectables